Affiliated with a Castle Connolly Top Hospital
Who is Dr. Relman, Infectious Disease Specialist in Palo Alto, CA?
Dr. David Relman, MD is an Infectious Disease Specialist, who primarily practices in Palo Alto, CA with 1 additional practice location. He is board certified. Dr. Relman graduated from Harvard Medical School, Boston, Massachusetts and completed his residency at Mass Gen Hosp, Internal Medicine. Dr. Relman is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Relman’s office at (650) 852-3308.
Where did Dr. Relman go to medical school and complete their residency?
Residency: Mass Gen Hosp, Internal Medicine
Medical School: Harvard Medical School, Boston, Massachusetts | Harvard Medical School, Boston, Massachusetts
Is Dr. Relman board certified as an Infectious Disease Specialist?
Yes, Dr. David Relman, MD is board certified by the American Board of Internal Medicine
What languages does Dr. Relman speak?
Dr. Relman and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does an Infectious Disease Specialist like Dr. Relman typically treat?
As an Infectious Disease Specialist, conditions treated by Dr. David Relman may include:
Please contact Dr. Relman's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does an Infectious Disease Specialist like Dr. Relman typically perform?
As an Infectious Disease Specialist, procedures performed by Dr. David Relman may include:
- Epidemiology Consultation
- Epidemiology Follow Up
- HIV / AIDS Consultation
- HIV / AIDS Follow Up
- Human Papillomavirus (HPV) Vaccine
- Infection Follow Up
- Lumbar Puncture
- Pertussis Vaccine
Please contact Dr. Relman's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Relman accept my insurance?
Please contact Dr. Relman's office to confirm accepted insurance plans.
Where is Dr. Relman's office located?
Dr. David Relman's Primary Practice
3801 Miranda Ave # 154T
Palo Alto, CA 94304
(650) 852-3308
Recognitions
Publications
sal Microenvironments and Interspecific Interactions Influence sal Microbiota Complexity and S
, 2013
Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin
, 2013
Metagenomics, Infectious Disease Diagnostics
, 2013
Type I Interferon Suppresses Type II Interferon-Triggered Human Anti-Mycobacterial Responses
, 2013
The Increasingly Compelling Moral Responsibilities of Life Scientists
, 2013
Undernutrition-Looking Within for Answers
, 2013
Distinct Distal Gut Microbiome Diversity and Composition
, 2013
Microbiome Assembly across Multiple Body Sites in Low-Birthweight Infants.
, 2013
Time series community genomics alysis reveals rapid shifts in bacterial species, strains
, 2013
Restoration of the gut microbial habitat as a disease therapy
, 2013
Temporal Dymics of the Transcriptiol Response to Dengue Virus Infection in Nicaraguan Children
, 2012
Comparisons of clustered regularly interspaced short palindromic repeats
, 2012
The human microbiome: ecosystem resilience and health
, 2012
Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota
, 2012
MICROBIOLOGY Learning about who we are
, 2012
The Application of Ecological Theory Toward an Understanding of the Human Microbiome
, 2012
Microbiota-Targeted Therapies: An Ecological Perspective
, 2012
Single-cell sequencing provides clues about the host interactions of segmented filamentous bacteria
, 2012
Creating a Mammalian-Transmissible A
, 2012
Presumed Guilt in the Anthrax Case Response
, 2012
Evidence of a robust resident bacteriophage population revealed through alysis of the human
, 2012
Public health and biosecurity. Adaptations of avian flu virus are a cause for concern.
, 2012
Policy: Adaptations of avian flu virus are a cause for concern.
, 2012
American Anthrax Fear, Crime, and the Investigation of the tion's Deadliest Bioterror Attack
, 2012
Comparisons of distance methods for combining covariates and abundances in microbiome studies.
, 2012
Modulation of the Host Interferon Response
, 2011
Transcriptiol Profiling of the Iron Starvation Response
, 2011
Microbial Genomics and Infectious Diseases
, 2011
Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen
, 2011
Minimum information about a marker gene sequence (MIMARKS)
, 2011
Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity
, 2011
Incomplete recovery
, 2011
Transforming Growth Factor-beta Sigling Pathway in Patients With Kawasaki Disease
, 2011
Transforming growth factor-beta sigling pathway in patients with Kawasaki disease.
, 2011
Strain-resolved community genomic alysis of gut microbial colonization in a premature infant
, 2011
Stunned Silence: Gene Expression Programs in Human Cells Infected with Monkeypox or Vaccinia Virus
, 2011
Alysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within
, 2011
SmashCell: a software framework for the alysis of single-cell amplified genome sequences
, 2010
Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation
, 2010
Microbial invasion of the amniotic cavity in pregncies with small-for-gestatiol-age fetuses
, 2010
Bacterial diversity in the oral cavity of 10 healthy individuals
, 2010
Genetic technologies. Synthetic life, ethics, tiol security, and public discourse.
, 2010
Preterm premature rupture of the membranes: current approaches to evaluation and magement
, 2010
The biological century: coming to terms with risk in the life sciences
, 2010
Dissecting Interferon-Induced Transcriptiol Programs in Human Peripheral Blood Cells
, 2010
Microbial threat lists: obstacles in the quest for biosecurity?
, 2010
2020 visions
, 2010
A molecular investigation of the microbial diversity
, 2009
Gene Transcript Abundance Profiles Distinguish Kawasaki Disease from Adenovirus Infection
, 2009
Majority Rules? Tallying the Microbial Census in an Abscess by Means of Molecular Methods
, 2009
tural-host animal models indicate functiol interchangeability between the filamentous
, 2009
Cross-talk in the gut
, 2009
CHARACTERIZATION OF THE GENE EXPRESSION PROGRAMS ASSOCIATED WITH DISEASE SEVERITY IN ACUTE
, 2008
Modulation of the NF-kappa B Pathway by Bordetella pertussis Filamentous Hemagglutinin
, 2008
The Pervasive Effects of an Antibiotic on the Human Gut Microbiota
, 2008
Exploring Microbial Diversity and Taxonomy Using SSU rR Hypervariable Tag Sequencing
, 2008
'Til death do us part': coming to terms with symbiotic relationships - Foreword
, 2008
Microbial Prevalence, Diversity and Abundance in Amniotic Fluid During Preterm Labor
, 2008
Comparative Alysis of Viral Gene Expression Programs during Poxvirus Infection
, 2008
Learning to appreciate our differences
, 2008
Microbiology in the post-genomic era
, 2008
Linking microbial phylogeny to metabolic activity at the single
, 2008
Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors
, 2008
Building a better virus trap
, 2007
An ecological and evolutiory perspective on human-microbe mutualism and disease
, 2007
Dissecting biological dark matter with single-cell genetic alysis of rare
, 2007
Development of the human infant intestil microbiota
, 2007
Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis
, 2007
Patterns of host genome
, 2007
The role of microbes in Crohn's disease
, 2007
The temporal program of peripheral blood gene expression
, 2007
The importance of individuals and scale: moving towards single cell microbiology
, 2007
Gene-expression patterns reveal underlying biological processes in Kawasaki disease
, 2007
Differential NF-kappaB responses induced by Bordetella pertussis Filamentous-Hemagglutinin
, 2007
How bacterial communities expand functiol repertoires
, 2006
Characterization of a highly conserved island
, 2006
Gene expression programs in adults with acute dengue infections
, 2006
Growth phase- and nutrient limitation
, 2006
A brave new world in the life sciences
, 2006
Assembly of the human intestil microbiota
, 2006
Metagenomic alysis of the human distal gut microbiome
, 2006
Early days: genomics and human responses to infection
, 2006
Significant gene order
, 2006
In search of biosecurity
, 2006
Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS
, 2006
Molecular alysis of the bacterial microbiota in the human stomach
, 2006
Bioterrorism - Preparing to fight the next war
, 2006
Rapid quantitative profiling of complex microbial populations
, 2006
Genomic features of Bordetella parapertussis clades with distinct host species specificity
, 2006
Bordetella pertussis, the causative agent of whooping cough
, 2005
Timing in collection of stool samples - Response
, 2005
Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma
, 2005
Diversity of the human intestil microbial flora
, 2005
Genomewide alysis of the host response to malaria in Kenyan children
, 2005
VCAM-1 expression on CD8(+) cells correlates with enhanced anti-HIV suppressing activity
, 2005
Exploring the potential of variola virus infection of cynomolgus macaques
, 2004
The host response to smallpox
, 2004
Methanogenic Archaea and human periodontal disease
, 2004
Bordetella species are distinguished by patterns of substantial gene loss and host adaptation
, 2004
Bordetella pertussis infection of primary human monocytes alters HLA-DR expression
, 2004
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock
, 2004
Public health - Understanding threats to scientific openness
, 2003
Shedding light on microbial detection
, 2003
Single-cell enumeration of an uncultivated TM7 subgroup in the human subgingival crevice
, 2003
Cultivation of Tropheryma whipplei from cerebrospil fluid
, 2003
Lethal invasive cestodiasis in immunosuppressed patients
, 2003
Smallpox vaccition - Reply
, 2003
Alysis of conserved non-rR genes of Tropheryma whipplei
, 2003
Prevalence of bacteria of division TM7 in human subgingival plaque
, 2003
Engineered antibodies to treat whooping cough.
, 2003
Sequencing and alysis of the genome of the Whipple's disease bacterium Tropheryma whipplei
, 2003
Individuality and variation in gene expression patterns in human blood
, 2003
The complexity of the inflammatory response to meningococcal sepsis revealed by gene expression
, 2003
Archaea and their potential role in human disease
, 2003
Progression of the lesion at the site of inoculation after smallpox vaccition
, 2003
Images in clinical medicine
, 2003
Individuality and variation in gene expression patterns in human blood.
, 2003
Role of phosphatidylinositol 3-kise in the binding of Bordetella pertussis to human monocytes
, 2002
New technologies, human-microbe interactions, and the search for previously unrecognized pathogens
, 2002
Molecular identification of cyanobacteria
, 2002
Genome-wide responses of a pathogenic bacterium to its host
, 2002
Mining the tural world for new pathogens
, 2002
Smallpox research activities: US Interagency collaboration, 2001
, 2002
Genomics and microbiology - Microbial forensics - Cross-examining pathogens
, 2002
Sequence variability in the first interl transcribed spacer region within
, 2002
The periodontal-systemic connection
, 2002
Identification of Cardiobacterium hominis by broad
, 2002
Human herpesvirus 8 and sarcoidosis
, 2002
The human body as microbial observatory
, 2002
Broad-range bacterial detection and the alysis of unexplained death and critical illness
, 2002
Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes
, 2002
Stereotyped and specific gene expression programs in human inte
What is Dr. Relman's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Relman's National Provider Identifier (NPI) number is 1326136706.
What common questions do patients ask about Dr. Relman?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Relman
What is Dr. David Relman's specialty?
Dr. Relman is a Infectious Disease Specialist near Palo Alto, CA.
What does an Infectious Disease Specialist do?
An internist who deals with infectious diseases of all types and in all organ systems. Conditions requiring selective use of antibiotics call for this special skill. This physician often diagnoses and treats AIDS patients and patients with fevers which have not been explained. Infectious disease specialists may also have expertise in preventive medicine and travel medicine.
Is this Dr. David Relman affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Relman is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see an Infectious Disease Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see an Infectious Disease Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is David Relman accepting new patients in Palo Alto, CA?
Yes, Dr. David Relman is accepting new patients at this time.
Does Dr. David Relman offer online booking?
Please contact Dr. Relman's office at (650) 852-3308 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with David Relman?
Please contact Dr. Relman's office at (650) 852-3308 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. David Relman have?
Dr. David Relman is certified by the American Board of Internal Medicine.
Other Infectious Disease Specialist Near Palo Alto, CA
Infectious Disease Specialist
Accepting patients
Infectious Disease Specialist
Accepting patientsInfectious Disease Specialist
Accepting patients